Cargando…

Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood–Brain Barrier in vivo and in vitro

Ischemia/reperfusion injury is a major cause of acute kidney injury (AKI). AKI is characterized by a sudden decrease in kidney function, systemic inflammation, oxidative stress, and dysregulation of the sodium, potassium, and water channels. While AKI leads to uremic encephalopathy, epidemiological...

Descripción completa

Detalles Bibliográficos
Autores principales: Burek, Malgorzata, Burmester, Sandra, Salvador, Ellaine, Möller-Ehrlich, Kerstin, Schneider, Reinhard, Roewer, Norbert, Nagai, Michiaki, Förster, Carola Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688901/
https://www.ncbi.nlm.nih.gov/pubmed/33281613
http://dx.doi.org/10.3389/fphys.2020.569881
_version_ 1783613752072994816
author Burek, Malgorzata
Burmester, Sandra
Salvador, Ellaine
Möller-Ehrlich, Kerstin
Schneider, Reinhard
Roewer, Norbert
Nagai, Michiaki
Förster, Carola Y.
author_facet Burek, Malgorzata
Burmester, Sandra
Salvador, Ellaine
Möller-Ehrlich, Kerstin
Schneider, Reinhard
Roewer, Norbert
Nagai, Michiaki
Förster, Carola Y.
author_sort Burek, Malgorzata
collection PubMed
description Ischemia/reperfusion injury is a major cause of acute kidney injury (AKI). AKI is characterized by a sudden decrease in kidney function, systemic inflammation, oxidative stress, and dysregulation of the sodium, potassium, and water channels. While AKI leads to uremic encephalopathy, epidemiological studies have shown that AKI is associated with a subsequent risk for developing stroke and dementia. To get more insights into kidney–brain crosstalk, we have created an in vitro co-culture model based on human kidney cells of the proximal tubule (HK-2) and brain microvascular endothelial cells (BMEC). The HK-2 cell line was grown to confluence on 6-well plates and exposed to oxygen/glucose deprivation (OGD) for 4 h. Control HK-2 cells were grown under normal conditions. The BMEC cell line cerebED was grown to confluence on transwells with 0.4 μm pores. The transwell filters seeded and grown to confluence with cereEND were inserted into the plates with HK-2 cells with or without OGD treatment. In addition, cerebEND were left untreated or treated with uremic toxins, indole-3-acetic acid (IAA) and indoxyl sulfate (IS). The protein and mRNA expression of selected BBB-typical influx transporters, efflux transporters, cellular receptors, and tight junction proteins was measured in BMECs. To validate this in vitro model of kidney–brain interaction, we isolated brain capillaries from mice exposed to bilateral renal ischemia (30 min)/reperfusion injury (24 h) and measured mRNA and protein expression as described above. Both in vitro and in vivo systems showed similar changes in the expression of drug transporters, cellular receptors, and tight junction proteins. Efflux pumps, in particular Abcb1b, Abcc1, and Abcg2, have shown increased expression in our model. Thus, our in vitro co-culture system can be used to study the cellular mechanism of kidney and brain crosstalk in renal ischemia/reperfusion injury.
format Online
Article
Text
id pubmed-7688901
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76889012020-12-03 Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood–Brain Barrier in vivo and in vitro Burek, Malgorzata Burmester, Sandra Salvador, Ellaine Möller-Ehrlich, Kerstin Schneider, Reinhard Roewer, Norbert Nagai, Michiaki Förster, Carola Y. Front Physiol Physiology Ischemia/reperfusion injury is a major cause of acute kidney injury (AKI). AKI is characterized by a sudden decrease in kidney function, systemic inflammation, oxidative stress, and dysregulation of the sodium, potassium, and water channels. While AKI leads to uremic encephalopathy, epidemiological studies have shown that AKI is associated with a subsequent risk for developing stroke and dementia. To get more insights into kidney–brain crosstalk, we have created an in vitro co-culture model based on human kidney cells of the proximal tubule (HK-2) and brain microvascular endothelial cells (BMEC). The HK-2 cell line was grown to confluence on 6-well plates and exposed to oxygen/glucose deprivation (OGD) for 4 h. Control HK-2 cells were grown under normal conditions. The BMEC cell line cerebED was grown to confluence on transwells with 0.4 μm pores. The transwell filters seeded and grown to confluence with cereEND were inserted into the plates with HK-2 cells with or without OGD treatment. In addition, cerebEND were left untreated or treated with uremic toxins, indole-3-acetic acid (IAA) and indoxyl sulfate (IS). The protein and mRNA expression of selected BBB-typical influx transporters, efflux transporters, cellular receptors, and tight junction proteins was measured in BMECs. To validate this in vitro model of kidney–brain interaction, we isolated brain capillaries from mice exposed to bilateral renal ischemia (30 min)/reperfusion injury (24 h) and measured mRNA and protein expression as described above. Both in vitro and in vivo systems showed similar changes in the expression of drug transporters, cellular receptors, and tight junction proteins. Efflux pumps, in particular Abcb1b, Abcc1, and Abcg2, have shown increased expression in our model. Thus, our in vitro co-culture system can be used to study the cellular mechanism of kidney and brain crosstalk in renal ischemia/reperfusion injury. Frontiers Media S.A. 2020-11-12 /pmc/articles/PMC7688901/ /pubmed/33281613 http://dx.doi.org/10.3389/fphys.2020.569881 Text en Copyright © 2020 Burek, Burmester, Salvador, Möller-Ehrlich, Schneider, Roewer, Nagai and Förster. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Burek, Malgorzata
Burmester, Sandra
Salvador, Ellaine
Möller-Ehrlich, Kerstin
Schneider, Reinhard
Roewer, Norbert
Nagai, Michiaki
Förster, Carola Y.
Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood–Brain Barrier in vivo and in vitro
title Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood–Brain Barrier in vivo and in vitro
title_full Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood–Brain Barrier in vivo and in vitro
title_fullStr Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood–Brain Barrier in vivo and in vitro
title_full_unstemmed Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood–Brain Barrier in vivo and in vitro
title_short Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood–Brain Barrier in vivo and in vitro
title_sort kidney ischemia/reperfusion injury induces changes in the drug transporter expression at the blood–brain barrier in vivo and in vitro
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688901/
https://www.ncbi.nlm.nih.gov/pubmed/33281613
http://dx.doi.org/10.3389/fphys.2020.569881
work_keys_str_mv AT burekmalgorzata kidneyischemiareperfusioninjuryinduceschangesinthedrugtransporterexpressionatthebloodbrainbarrierinvivoandinvitro
AT burmestersandra kidneyischemiareperfusioninjuryinduceschangesinthedrugtransporterexpressionatthebloodbrainbarrierinvivoandinvitro
AT salvadorellaine kidneyischemiareperfusioninjuryinduceschangesinthedrugtransporterexpressionatthebloodbrainbarrierinvivoandinvitro
AT mollerehrlichkerstin kidneyischemiareperfusioninjuryinduceschangesinthedrugtransporterexpressionatthebloodbrainbarrierinvivoandinvitro
AT schneiderreinhard kidneyischemiareperfusioninjuryinduceschangesinthedrugtransporterexpressionatthebloodbrainbarrierinvivoandinvitro
AT roewernorbert kidneyischemiareperfusioninjuryinduceschangesinthedrugtransporterexpressionatthebloodbrainbarrierinvivoandinvitro
AT nagaimichiaki kidneyischemiareperfusioninjuryinduceschangesinthedrugtransporterexpressionatthebloodbrainbarrierinvivoandinvitro
AT forstercarolay kidneyischemiareperfusioninjuryinduceschangesinthedrugtransporterexpressionatthebloodbrainbarrierinvivoandinvitro